The 5-HT2 receptor antagonist, MDL 28,133A, disrupts the serotonergic-dopaminergic interaction mediating the neurochemical effects of 3,4-methylenedioxymethamphetamine.

Source:http://linkedlifedata.com/resource/pubmed/id/1425989

Eur. J. Pharmacol. 1992 Sep 22 220 2-3 151-9

Download in:

View as

Triples

General Info

PMID
1425989